UTIs are becoming more deadly, thanks to AMR — CSIRO
06 April, 2022The spread of drug-resistant bacteria in the community is increasing the risk of death for common infections such as urinary tract infections (UTIs) — which affect around one in two women and one in 20 men in their lifetime.
Pre-surgery support could help patients quit smoking
04 April, 2022Offering mailed nicotine replacement therapy (NRT) and Quitline support to patients encouraged almost one-third of smokers to quit before their elective surgery.
Ivor Lewis esophagectomy surgery performed at Mater Townsville
25 March, 2022The minimally invasive Ivor Lewis esophagectomy surgery has been successfully performed on a patient at Mater Private Hospital Townsville.
Funding to support on-site pharmacists in residential aged-care facilities
25 March, 2022The government has announced $345.7m funding for on-site pharmacists and community pharmacy services in government-funded residential aged care facilities (RACFs).
Hospital pharmacists' role in COVID-19 treatments
23 March, 2022 by Kristin Michaels, SHPA Chief Executive | Supplied by: The Society of Hospital Pharmacists of AustraliaThe introduction of oral antiviral treatments calls on the expertise and services of hospital pharmacists as we progress towards the endemic stage of this pandemic.
New ultrasound guidelines urge for parent-centred communication
23 March, 2022The Australasian Society for Ultrasound in Medicine (ASUM) has launched new guidelines mapping a way forward for sonographers to open dialogue and be more transparent with obstetric patients about the results of their scans.
Digital 'twins' cut surgery time for children with severe hip deformities
23 March, 2022Dr Martina Barzan and her team have created digital 'twins' of child patients that would enable surgeons to better plan, test and execute complex surgeries.
COVID-19 taskforce publishes new risk classification tool
21 March, 2022The National COVID-19 Clinical Evidence Taskforce (NCCET) has developed a risk classification tool to guide clinicians making decisions about which people are most likely to benefit from drugs.
How deceased ovarian cancer patients are safeguarding their families' health
21 March, 2022A new Peter Mac-led study has posthumously tested samples from ovarian cancer patients who missed the chance for genetic testing before they died of the disease.
How antimicrobial resistance spreads inside the human gut
21 March, 2022A collaboration between the Hudson Institute of Medical Research and the Wellcome Sanger Institute, Cambridge UK, explores how antimicrobial resistance (AMR) spreads inside the human gut.
World-first lung scanner installed at the Prince of Wales Hospital
18 March, 2022The world's first dedicated lung scanner, XV Scanner, developed by local researcher Dr Andreas Fouras, has been installed at the Prince of Wales Hospital, Sydney.
WA pharmacist recognised for leadership, contribution to medical safety
16 March, 2022Kerry Fitzsimons has been recognised by the Society of Hospital Pharmacists of Australia (SHPA) for her leadership and contribution to medical safety in Western Australia and beyond.
Locally developed screening tool detects autism at 11 months
14 March, 2022A new screening tool, developed by researchers from La Trobe University, helps detect autism in very young children.
Shingrix approved for Australians 18+ at high risk
14 March, 2022GSK Australia's Shingrix is available on the private market for the prevention of shingles and post-herpetic neuralgia in people aged 18 years and over who are at increased risk of shingles.
2022 influenza control: virologist recommends four actions
09 March, 2022With the lifting of border restrictions and quarantine regulations, Australians can anticipate the reintroduction of influenza, according to the authors of an editorial published by the Medical Journal of Australia.
